[This entry is marked for removal.]

Hitachi Medical Systems America, Inc. (HMSA), was a major provider of magnetic resonance imaging systems in the United States. Hitachi had more than 2300 installed permanent magnet MR imaging systems worldwide. As a full-line supplier of medical imaging equipment in Japan, Hitachi Medical Corporation (HMC) founded HMSA to provide a direct link to the U.S. marketplace. Altaire™ , the open MR system from Hitachi, extends the family of open MRI products.

In December 2019 Japan's Fujifilm announced the acquisition of Hitachi's diagnostic imaging business for 179 billion yen ($1.63 billion). This includes Hitachi’s CT, MRI, X-ray, and ultrasound imaging operations, also its electronic health record business. Fujifilm expects the deal to close in July 2020 subject to regulatory clearances.

MRI Scanners:

0.3T to 0.7T:
1.5T:

Liver imaging can be performed with sonography, computed tomography (CT) and magnetic resonance imaging (MRI). Ultrasound is, caused by the easy access, still the first-line imaging method of choice; CT and MRI are applied whenever ultrasound imaging yields vague results. Indications are the characterization of metastases and primary liver tumors e.g., benign lesions such as focal nodular hyperplasia (FNH), adenoma, hemangioma and malignant lesions (cancer) such as hepatocellular carcinomas (HCC). The decision, which medical imaging modality is more suitable, MRI or CT, is dependent on the different factors. CT is less costly and more widely available; modern multislice scanners provide high spatial resolution and short scan times but has the disadvantage of radiation exposure.
With the introduction of high performance MR systems and advanced sequences the image quality of MRI for the liver has gained substantially. Fast spin echo or single shot techniques, often combined with fat suppression, are the most common T2 weighted sequences used in liver MRI procedures. Spoiled gradient echo sequences are used as ideal T1 weighted sequences for evaluating of the liver. The repetition time (TR) can be sufficiently long to acquire enough sections covering the entire liver in one pass, and to provide good signal to noise. The TE should be the shortest in phase echo time (TE), which provides strong T1 weighting, minimizes magnetic susceptibility effects, and permits acquisition within one breath hold to cover the whole liver. A flip angle of 80° provides good T1 weighting and less of power deposition and tissue saturation than a larger flip angle that would provide comparable T1 weighting.
Liver MRI is very dependent on the administration of contrast agents, especially when detection and characterization of focal lesions are the issues. Liver MRI combined with MRCP is useful to evaluate patients with hepatic and biliary disease.
Gadolinium chelates are typical non-specific extracellular agents diffusing rapidly to the extravascular space of tissues being cleared by glomerular filtration at the kidney. These characteristics are somewhat problematic when a large organ with a huge interstitial space like the liver is imaged. These agents provide a small temporal imaging window (seconds), after which they begin to diffuse to the interstitial space not only of healthy liver cells but also of lesions, reducing the contrast gradient necessary for easy lesion detection. Dynamic MRI with multiple phases after i.v. contrast media (Gd chelates), with arterial, portal and late phase images (similar to CT) provides additional information.
An additional advantage of MRI is the availability of liver-specific contrast agents (see also Hepatobiliary Contrast Agents). Gd-EOB-DTPA (gadoxetate disodium, Gadolinium ethoxybenzyl dimeglumine, EOVIST Injection, brand name in other countries is Primovist) is a gadolinium-based MRI contrast agent approved by the FDA for the detection and characterization of known or suspected focal liver lesions.
Gd-EOB-DTPA provides dynamic phases after intravenous injection, similarly to non-specific gadolinium chelates, and distributes into the hepatocytes and bile ducts during the hepatobiliary phase. It has up to 50% hepatobiliary excretion in the normal liver.
Since ferumoxides are not eliminated by the kidney, they possess long plasmatic half-lives, allowing circulation for several minutes in the vascular space. The uptake process is dependent on the total size of the particle being quicker for larger particles with a size of the range of 150 nm (called superparamagnetic iron oxide). The smaller ones, possessing a total particle size in the order of 30 nm, are called ultrasmall superparamagnetic iron oxide particles and they suffer a slower uptake by RES cells. Intracellular contrast agents used in liver MRI are primarily targeted to the normal liver parenchyma and not to pathological cells. Currently, iron oxide based MRI contrast agents are not marketed.
Beyond contrast enhanced MRI, the detection of fatty liver disease and iron overload has clinical significance due to the potential for evolution into cirrhosis and hepatocellular carcinoma. Imaging-based liver fat quantification (see also Dixon) provides noninvasively information about fat metabolism; chemical shift imaging or T2*-weighted imaging allow the quantification of hepatic iron concentration.

See also Abdominal Imaging, Primovistâ„¢, Liver Acquisition with Volume Acquisition (LAVA), T1W High Resolution Isotropic Volume Examination (THRIVE) and Bolus Injection.

For Ultrasound Imaging (USI) see Liver Sonography at Medical-Ultrasound-Imaging.com.

Pulse sequences, designed to be insensitive to flow, e.g. at every even echo, a spin echo sequence is not flow sensitive. Velocity compensation is achieved by using gradients, which are either symmetrical around a 180° pulse and switched on twice as is the case for motion compensated spin echo pulse sequences, or two antisymmetrical gradient lobes without 180° pulse, which is the way to produce a velocity compensated gradient echo pulse sequence.
The signal of the second echo (and all other even echoes) is independent of the velocity of the object. Thus, velocity-based motion effects stemming from the entire voxel or from spins within a voxel (intravoxel incoherent motion) are suppressed with such pulse sequences.
If higher order motion is relevant, as it may be in turbulent jets across valves, acceleration and jerk effects can also be compensated for by the use of appropriate combinations of gradient- and radio frequency pulses.
With the increasingly stronger gradients, echo times in MR systems can be shortened to the point at which effects other than velocity effects hardly ever become relevant.

The navigator technique measures with an additional quick MR prepulse the position, of e.g. the diaphragm before data collecting. Similar respiratory conditions of the patient can be identified and used to synchronize image data acquisition so that respiration induced image blurring is minimized by either respiratory ordered phase encoding or respiratory gating.
The prepulse sequence images a small area perpendicular to the structure, which is moving. The contrast of the interface between the diaphragm and the lung should be high to permit easy automatic detection. After data acquisition, the position of the interface is automatically recorded and imaging data are only accepted when the position of the interface falls within a range of prespecified values.
This technique has the advantage of greater accuracy than other respiratory gating (therefore used for coronary angiography) and has no need for additional sensing MRI equipment, as the MR system itself provides it.

A measure of the noise performance of an amplifier or chain of amplifiers such as a MR receiver. In MR systems the preamplifier should have a very low noise figure to prevent significant degradation of the signal to noise ratio of the MR signal. Noise figure is a ratio in dB's, and is given by: 20 log [Vo/(ViG)] where Vi is the input thermal noise voltage, Vo is the amplifier output noise level and G is the voltage gain of the amplifier (when the input and output impedance's of the amplifier are equal).